Radiomics Analysis Based on MRI to Detect Brucella Spondylitis
Study Overview
Status
Status
Conditions
Conditions
Detailed Description
Study Type
Study Type
Enrollment (Estimated)
Enrollment
Contacts and Locations
Study Contact
Study Contact
- Name: Peng fei Qiao, MD
- Phone Number: 15904718239
- Email: 24853170@qq.com
Study Locations
-
-
Inner Mongolia
-
Hohhot, Inner Mongolia, China
- Recruiting
- Affiliated Hospital of Inner Mongolia Medical University
-
Contact:
- Peng fei Qiao
- Phone Number: 15904718239
- Email: 24853170@qq.com
-
Principal Investigator:
- Peng fei Qiao
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Outpatients/Inpatients
- Age 18-70 years
- Meet diagnostic criteria for brucellosis
- Meet symptoms of brucellosis spondylitis
- Voluntarily sign an informed consent form
- Can cooperate with MRI examination
Exclusion Criteria:
- Patients with serious diseases of other systems
- History of malignant tumors of the vertebral body
- History of tuberculosis
- Contraindications to magnetic resonance imaging
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The useful value of radiomics of MRI in BS clinical diagnosis.
Time Frame: December 2024
|
The investigators will validate the results.
The validation and external test cohorts will be used to evaluate the performance of the prediction models.
The micro-avg and macro-avg precision, true positive (TP), true negative (TN), false positive (FP), false negative (FN), accuracy, sensitivity, specificity, and F1 score of different models will be calculated.
Receiver operating characteristic (ROC) curves is going to be used to assess the sensitivity and specificity of the models, and the area under the ROC curve (AUC) was used to describe the discriminative power of the models.
The investigators think radiomics of MRI can provide a reliable basis for early damage in brucellosis spondylitis and provides evidence for early clinical intervention.
|
December 2024
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Study Director: Peng fei Qiao, MD, Affiliated Hospital of Inner Mongolia Medical University
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Estimated)
Primary Completion
Study Completion (Estimated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Estimated)
First Posted
Study Record Updates
Last Update Posted (Estimated)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- AHInnerMongolia-BS
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.